Cryptococcosis
📧 Sign up to get email alerts when something new happens for Cryptococcosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-06-12EMA Authorised: Posaconazole Accord (posaconazole) — Accord Healthcare S.L.U.
Authorised status for Posaconazole Accord, MAH Accord Healthcare S.L.U., in the therapeutic area of mycoses.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Fungal Infection Susceptibility
This clinical trial update from NIAID reports ongoing recruitment to study susceptibility to fungal infections caused by Cryptococcus. The c…
-
FDA approval · 2026-01-14FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride (intravenous formulation), adding this generic IV flu…
-
FDA approval · 2025-06-02FDA Approved: AMPHOTERICIN B — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for Amphotericin B as a generic drug by Heritage Pharmaceuticals (Avet) to treat serious systemic funga…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Completed prospective observational study assessing the incidence of opportunistic fungal infections, including Pneumocystis jirovecii pneum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-13FDA Approved: POSACONAZOLE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for posaconazole from Mylan Institutional LLC, updating the approval for the generic product.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Inpatient Package to Reduce HIV and AIDS-related Death in Zambia [NA]
A clinical trial update notes that an inpatient care package designed to reduce HIV/AIDS-related deaths in Zambia has completed.
-
FDA approval · 2023-07-17FDA Approved: FLUCONAZOLE IN SODIUM CHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for Fluconazole in Sodium Chloride, establishing an intravenous formulation of fluconazole. …
-
CLINICAL_TRIALS research · 2020-06-04Clinical Trial Update: Operational Research for Cryptococcal Antigen Screening [Phase 4]
Phase 4 operational research trial update on cryptococcal antigen screening, completed.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Cryptococcal Antigen Screening Plus Sertraline [Phase 3]
Phase 3 trial of cryptococcal antigen screening plus sertraline for cryptococcosis was terminated; results posted in 2019.
-
FDA approval · 2019-07-16FDA Approved: FLUCONAZOLE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Fluconazole from Zydus Lifesciences Limited, resulting in regulatory approval of this generic pr…
-
FDA approval · 2017-07-07FDA Approved: FLUCYTOSINE — Original Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' original application for Flucytosine (generic) to market the drug in the United States.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Cryptococcus Neoformans Infection in Patients Not Infected With HIV and Complications Associated With Cryptococcus Neoformans Infection
This completed clinical trial from the National Cancer Institute evaluated whether inherited polymorphisms in the innate immune system influ…
-
CLINICAL_TRIALS research · 2015-07-21Clinical Trial Update: Clinical Trial of Pulmonary Cryptococcosis in China
This entry provides an update on a Chinese clinical trial investigating pulmonary cryptococcosis, but no results or current status are discl…
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection [Phase 3]
Phase 3 pharmacokinetic study of the itraconazole oral solution JK1211 (Itrizole) in patients with invasive fungal infections; results have …
-
FDA approval · 2011-10-13FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for fluconazole by Rising Pharma Holdings, Inc., authorizing an updated generic product under the AN…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis [Phase 3]
A Phase 3 study is evaluating SPK-843 for pulmonary fungal infections including cryptococcosis and aspergillosis. The trial investigates eff…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of voriconazole for fungal infections has completed. The study included candidia…